Infinity Adaptis
Payments companies reported to CMS as associated with Infinity Adaptis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Infinity Adaptis, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Infinity Adaptis
These are the largest totals companies reported as associated with Infinity Adaptis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| William Davis | Charlotte, NC | Orthopaedic Surgery | $37,807.77 |
| Steven Haddad | Glenview, IL | Orthopaedic Surgery | $17,812.45 |
| Scott Ellis | New York, NY | Foot and Ankle Surgery | $6,977.65 |
| David Dalstrom | Seattle, WA | Foot and Ankle Surgery | $4,774.04 |
| Jason Patterson | Gilbert, AZ | Foot and Ankle Surgery | $4,235.02 |
| Jeremy Mccormick | Saint Louis, MO | Foot and Ankle Surgery | $3,561.54 |
| Karl Schweitzer | Raleigh, NC | Orthopaedic Surgery | $2,928.73 |
| William Mcgarvey | Katy, TX | Foot and Ankle Surgery | $2,850.05 |
| Gregory Berlet | Worthington, OH | Orthopaedic Surgery | $2,794.85 |
| Andrew Ebert | Austin, TX | Foot and Ankle Surgery | $2,600.17 |
Prescribed Infinity Adaptis?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.